Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma
FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells
Thalidomide-NH-amido-PEG1-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology
3-thiazolidin-3-yl]acetic acid
8 nM) very similar to that of Chrysamine-G
3-Demethylcolchicine - CAS# 7336-33-6 Catalog No.:M15950-C Preclinical evaluation of the BET3 Demethylcolchicine, a colchicine metabolite, possesses a hydroxy group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema. Product information CAS Number: 7336 33 6 Molecular Weight: 385. 41 Formula: C21H23NO6 Chemical Name: N [(10S) 5 hydroxy 3,4,14 trimethoxy 13 oxotricyclo[9. 5. 0. 0,]hexadeca 1(16),2,4,6,11,14 hexaen 10 yl]acetamide Smiles:
US$ 337.50
US$ 170.00
US$ 34.99
US$ 25.19